Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
10
×
boston blog main
life science
10
×
biotech
boston top stories
life sciences
national blog main
national top stories
event
national
novartis
.406 ventures
5g
6 river systems
accomplice
aclu
aerospace
alyce
amazon robotics
american well
amy villeneuve
angel investors
avapritinib
bioinnovation capital
biolabs
blueprint medicines
bluesnap
burlington
cancer
cancer drugs
capmatinib
chatbot
chemotherapy
cisco
cybersecurity
daraprim
data robot
david meredith
deals
defense
What
boston
life
medical
sciences
tech
accelerating
attend
biopharma's
biopharma’s
breakthroughs
digital
future
health
learn
registering
team
xcelerating
join
online
drug
public
address
approval
approves
biotech
bird
blueprint
cancer
carries
cash
certain
coming
covers
datarobot
designed
driving
early
ends
executive
facial
Language
unset
Current search:
xconomy.com
×
boston
×
" life science "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Join us this Wednesday for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes